RLF AgTech (ASX:RLF) signed an exclusive agreement with Axioma Biologicals to register, market, and sell the France-based agricultural biotech firm's liquid biostimulant products across Australia, China, and Asia, according to a Tuesday filing with the Australian bourse.
The agreement is effective until Sept. 30, 2026, with automatic two-year renewals until termination, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.